Nucleic Acid Isolation and Purification - Global Strategic Business Report: Capture the $3.9 Billion Revenue Surge by 2030 as Thermo Fisher, Qiagen, Danaher, Illumina, and Bio-Rad Battle for Share

Target automation, magnetic bead and microfluidic platforms for diagnostics, genomics and precision medicine; use tariff insights to optimize sourcing and supply chains.

Dublin, Nov. 10, 2026 (GLOBE NEWSWIRE) -- "Nucleic Acid Isolation and Purification - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

Global Nucleic Acid Isolation and Purification Market to Reach US$12 Billion by 2030

The global nucleic acid isolation and purification market was valued at US$8.1 billion in 2024 and is projected to reach US$12 billion by 2030, expanding at a compound annual growth rate (CAGR) of 6.7% during the forecast period. The comprehensive market report examines industry trends, growth drivers, competitive dynamics, regional opportunities and the effects of recent global tariff and trade developments.

Market Trends and Growth Drivers

Nucleic acid isolation and purification technologies are essential to genomics, molecular diagnostics, drug discovery, gene editing and precision medicine. Demand for high-quality DNA and RNA continues to increase as laboratories, healthcare providers and biopharmaceutical companies expand their use of polymerase chain reaction testing, Next -generation sequencing and other molecular analysis platforms.

Technological advances are improving the speed, accuracy and scalability of nucleic acid extraction. Automated extraction systems are gaining adoption in clinical and research laboratories because they support higher sample throughput while reducing manual processing errors. Magnetic bead-based purification, microfluidics and high-throughput platforms are also enabling faster sample preparation, lower reagent consumption and more consistent results.

The continued expansion of genomics and personalized medicine represents a significant market opportunity. Genomic data is increasingly used to support disease diagnosis, treatment selection and therapeutic development, particularly in oncology, infectious diseases and inherited disorders. Growth in liquid biopsy testing, including analysis of circulating tumor DNA and RNA, is further increasing demand for sensitive and reliable nucleic acid purification solutions.

Additional market growth is being supported by the rising incidence of cancer and genetic disorders, increased investment in gene therapy research, and demand for rapid molecular diagnostics. Government funding, regulatory support and public- and private-sector investment in genomics infrastructure are also contributing to the adoption of advanced extraction technologies.

Segment and Regional Outlook

• Products: The report analyzes nucleic acid isolation and purification kits, instruments and reagents.
• Applications: Coverage includes diagnostics, drug discovery and development, precision medicine, agriculture and animal research, and other applications.
• Kits: The nucleic acid isolation and purification kits segment is forecast to reach US$5.3 billion by 2030, growing at a CAGR of 5.9%.
• Instruments: The instruments segment is projected to expand at a CAGR of 8% over the analysis period.
• United States: The U.S. market was estimated at US$2.1 billion in 2024.
• China: China is forecast to grow at a CAGR of 9.8%, reaching US$2.8 billion by 2030.

The geographic analysis covers the United States, Canada, Japan, China, Europe, Asia-Pacific, Latin America, the Middle East and Africa. Country-level coverage includes major markets such as Germany, France, the United Kingdom, Italy, Spain, India, South Korea, Australia, Brazil, Mexico, Saudi Arabia and the United Arab Emirates.

Domain Expert Insights

The report tracks how automation, magnetic bead-based purification, microfluidics and Next -generation sequencing requirements are reshaping product development and laboratory workflows. It also evaluates how precision medicine, liquid biopsy, gene therapy and infectious disease testing are influencing demand across clinical, academic and commercial settings.

Expert commentary from economists, trade specialists and industry professionals provides context for changing market conditions. The analysis assesses supply chain disruptions, sourcing strategies, regional manufacturing shifts and competitive positioning to help organizations identify emerging opportunities and mitigate operational risks.

Tariff, Trade and Economic Analysis

This edition incorporates recent global tariff negotiations and trade developments across more than 180 countries. It examines supply chain turbulence, sourcing disruptions and geographic realignment, with particular attention to the trade tensions and tariff policies that affected the market in 2025.

Global and regional forecasts through 2030 have been adjusted to reflect tariff impacts, economic uncertainty and structural changes in globalization. The report also includes historical analysis from 2015 through 2023, updated 2025 market share estimates, regional economic indicators, and assessments of product and process innovation.

Report Benefits

• Independent analysis of annual sales and market forecasts from 2024 through 2030.
• Detailed evaluation of the global nucleic acid isolation and purification market by product, application and geography.
• Competitive intelligence covering major companies, global brands and market positioning.
• Analysis of market drivers, restraints, technology trends and future revenue opportunities.
• Strategic insights designed to support investment planning, competitive benchmarking and business development.
• Complimentary report updates for one year.

Companies Featured

The report profiles 18 companies operating in the nucleic acid isolation and purification market. Featured participants include Agilent Technologies , Inc.; Bio-Rad Laboratories , Inc.; Danaher Corporation; GE Healthcare; Illumina, Inc.; Merck KGaA KGaA; New England Biolabs, Inc.; Promega Corporation; Qiagen N.V.; Roche Molecular Systems, Inc.; Takara Bio, Inc.; and Thermo Fisher Scientific , Inc.

Key Questions Addressed

• How will the global nucleic acid isolation and purification market evolve through 2030?
• Which technologies, applications and product segments offer the strongest growth potential?
• How are tariffs, supply chain changes and economic uncertainty affecting market forecasts?
• Which regional markets are expected to record the fastest expansion?
• How are leading companies positioned within the competitive landscape?

By combining market forecasts, regional analysis, competitive intelligence and expert commentary, the report provides decision-makers with actionable insights into the technologies and commercial forces shaping the global nucleic acid isolation and purification industry.

Key Attributes:

Report Attribute	Details
No. of Pages	161
Forecast Period	2024 - 2030
Estimated Market Value (USD) in 2024	$8.1 Billion
Forecasted Market Value (USD) by 2030	$12 Billion
Compound Annual Growth Rate	6.7%
Regions Covered	Global

For more information about this report visit https://www.researchandmarkets.com/r/t871az

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: 
CONTACT: ResearchAndMarkets.com 
         Laura Wood, Senior  Press Manager 
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470 
         For U.S./ CAN Toll Free Call 1-800-526-8630 
         For GMT Office Hours Call +353-1-416-8900